Expand GMED Menu
GMED MENU

Globus Medical Class A (GMED) closed at $72.14 on November 13, 2026, down 0.2% from the previous close, on volume of 1,475,995 shares (30-day average 1,769,363).

Key numbers
  • Last close: $72.14 (November 13, 2026)
  • 52-week range: $70.40 to $101.40
  • Market value: $9.7 billion
  • 30-day implied volatility (IV30): 33.7%
  • Option volume: 448 contracts (19 calls, 429 puts); 30-day average 403

Data as of November 13, 2026.

GMED Stock Summary and Trading Ideas (Globus Medical Class A | NYSE:GMED)

Charts for Today's Stock Price and Implied Volatility in Globus Medical Class A

13-Nov-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for GMED by Theoretical Edge and Win Rates

Sentiment

Largest Multi-Leg Option Trades (30 Days)

#DateStrategyLegsContracts
1 Nov 10, 2026 Put Spread 20-Nov-2675 : 80 P 2,000
2-3 The next 2 largest trades are for Premium members. Start a 7-day free trial

Premium Feature

Login|Subscribe

Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 13, 2026. See the 10 largest for 30, 60 and 90 days

Trading Statistics

Key Ratios

Globus Medical Class A (GMED) Frequently Asked Questions

What does Globus Medical Class A do?

Through innovative technology and M&A activity, Globus Medical transformed into the number two medical device manufacturer in the competitive spine market. The firm was founded in 2003 with a heavy focus on internal research and development but vaulted its market share in 2023 through a merger with former competitor NuVasive. In 2025, the company acquired Nevro, a smaller player that specialized in spinal cord stimulation therapy. Globus Medical reports two business segments, musculoskeletal solutions and enabling technologies, which consist of implants used in surgery and associated technologies that assist the physician.

What symbol and exchange does Globus Medical Class A shares trade?

Globus Medical Class A trades on the NYSE stock market under the symbol GMED.

What is Globus Medical Class A stock price doing today?

As of November 13, 2026, GMED stock price declined to $72.14 with 1,475,995 million shares trading.

What is Globus Medical Class A's Beta?

GMED has a beta of 0.20, meaning it tends to be less sensitive to market movements. GMED has a correlation of 0.00 to the broad based SPY ETF.

How much is Globus Medical Class A worth?

GMED has a market cap of $9.69 billion. This is considered a Mid Cap stock.

How much money does Globus Medical Class A make?

Last quarter Globus Medical Class A reported $764 million in Revenue and $1.23 earnings per share. This fell short of revenue expectation by $-29 million and exceeded earnings estimates by $.03.

What is the highest and lowest price Globus Medical Class A traded in the last 3 year period?

In the last 3 years, GMED traded as high as $101.40 and as low as $44.02.

What are the top ETFs holding Globus Medical Class A?

The top ETF exchange traded funds that GMED belongs to (by Net Assets): IJH, VTI, VB, VBK, VXF.

Is Globus Medical Class A (GMED) a good investment?

GMED has underperformed the market in the last year with a price return of -14.1% while the SPY ETF gained +13.4%. GMED has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -16.1% and -7.6%, respectively, while the SPY returned -2.8% and -0.2%, respectively.

What are the support and resistance levels for Globus Medical Class A (GMED)?

GMED support price is $70.08 and resistance is $74.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GMED shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes